Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
PET Clinics|November 28, 2022
PET-Computed Tomography in Bone and Joint InfectionsSarvesh Loharkar, Sandip Basu
World Journal of Nuclear Medicine|May 24, 2023
Post-Topotecan Mixed Response and 'Redifferentiation-akin' Phenomenon on Dual Tracer PET-CT in Multiple Treatment-Resistant Metastatic Neuroendocrine NeoplasmSarvesh Loharkar, Sandip Basu
Journal of Nuclear Medicine Technology|April 20, 2022
Metachronous Adenocarcinoma of the Lung in the Setting of Metastatic Gastric Neuroendocrine Tumor: Value of Elucidating Discordance on Dual-Tracer PET/CT with Ki-67 IndexSarvesh Loharkar, Sandip Basu
World Journal of Nuclear Medicine|April 14, 2021
Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging (<sup>18</sup>F-fluorodeoxyglucose and <sup>68</sup>Ga-DOTATATE) correlates and their treatment implicationsSarvesh Loharkar, Sandip Basu
World Journal of Nuclear Medicine|March 16, 2023
Hurthle Cell Thyroid Carcinoma with Liver and Paraaortic Abdominal Nodal Metastasis: Progression on Sorafenib Therapy after Initial Disease StabilizationSarvesh Loharkar, Sandip Basu
World Journal of Nuclear Medicine|March 16, 2023
Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine ScanSarvesh Loharkar, Sandip Basu
The Journal of Laryngology and Otology|October 25, 2024
Clinicopathological characteristics of collision tumours of thyroid in the clinical setting of medullary thyroid carcinomaAshwini Chalikandy, Sarvesh Loharkar, Sandip Basu
Clinical Nuclear Medicine|November 12, 2020
18F-FDG PET/CT in a Rare Case of Poland Syndrome and Gastric CancerSarvesh Loharkar, Gaurav Malhotra, Ramesh V Asopa
Cancer Biotherapy & Radiopharmaceuticals|December 15, 2021
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[<sup>177</sup>Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [<sup>177</sup>Lu]Lu-DOTA-TATE and the Trend with Multiple CyclesKamaldeep, Sarvesh Loharkar, Tapas Das, et al.
Pageof 1